BusinessCorbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) to Ring The Nasdaq Stock Market Closing BellBy Nasdaq OMXDec 5, 2016, 3:00 PM UTC
BusinessKaryopharm Presents Updated Phase 2b STORM Data at the American Society of Hematology 2016 Annual MeetingBy Nasdaq OMXDec 5, 2016, 12:30 AM UTC
BusinessKaryopharm Presents Updated Phase 2 SAIL Relapsed/Refractory AML Clinical Data at the American Society of Hematology 2016 Annual MeetingBy Nasdaq OMXDec 4, 2016, 5:30 PM UTC
BusinessTonix Pharmaceuticals to Present Clinical Data at the 55th Annual Meeting of the American College of Neuropsychopharmacology (ACNP)By Nasdaq OMXDec 2, 2016, 12:21 PM UTC
BusinessTonix Pharmaceuticals to Present at 9th Annual LD Micro Main Event Investor ConferenceBy Nasdaq OMXNov 30, 2016, 12:00 PM UTC
BusinessAchillion Announces Initiation of Patient Dosing by Janssen in a Global, Short Treatment-Duration Phase 2b Study of JNJ-4178 in Chronic HCVBy Nasdaq OMXNov 30, 2016, 11:05 AM UTC
BusinessNymox Reports Additional Positive Results From Completed Fexapotide BPH Phase 3 Studies Showing Significant Early Response and First-Line EfficacyBy Nasdaq OMXNov 29, 2016, 2:45 PM UTC
BusinessAXIM® Biotech Files IP Application on Propietary Method to Extract High-Purity THCBy Nasdaq OMXNov 29, 2016, 2:01 PM UTC
